Exercise of Options

RNS Number : 7448I

Hutchison China Meditech Limited

03 June 2014

 



Hutchison China MediTech Limited ("Chi-Med")

(AIM: HCM)

Exercise of Options

London: Tuesday, 3 June 2014: Chi-Med announces that it has issued 768,182 ordinary shares of US$1.00 each (the "Shares") following the exercise of options by Mr Christian Hogg, Executive Director and Chief Executive Officer of Chi-Med, at an exercise price of GBP1.09 per share on 3 June 2014.  The options, granted in June 2005, will lapse after ten years.

Following the issue of the Shares, which are expected to be held as a long term investment by Mr Hogg, Mr Hogg is beneficially interested in 1,088,182 Shares, representing 2.06% of the current issued share capital of Chi-Med.

Ends

Enquiries

Chi-Med     Christian Hogg, CEO	Telephone:      [phone]
Panmure Gordon (UK) Limited     Richard Gray     Andrew Potts	Telephone:      [phone]
Citigate Dewe Rogerson     Anthony Carlisle     David Dible	Telephone:      [phone] Mobile:             [phone] Mobile:             [phone]

 

About Chi-Med

Chi-Med is a China-based healthcare group focused on researching, developing, manufacturing and selling pharmaceuticals and health-related consumer products.  Its China Healthcare Division manufactures, markets and distributes prescription and over-the-counter pharmaceuticals in China.  Its Drug R&D Division focuses on discovering and developing innovative therapeutics in oncology and autoimmune diseases.  Its emerging Consumer Products Division focuses on organic and natural consumer products in Asia.

Chi-Med (LSE:HCM) is majority owned by the multinational conglomerate Hutchison Whampoa Limited (SEHK:13).  For more information, please visit: www.chi-med.com.

 

END

 

 

RDSEALKDEADLEFF